Taysha Gene Therapies, Inc.Taysha Gene Therapies, Inc.Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

No trades
See on Supercharts

Price target

6.590.000.00%
The 11 analysts offering 1 year price forecasts for TSHA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 11 analysts giving stock ratings to TSHA in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


TSHA EPS for the last quarter is −0.10 USD despite the estimation of −0.09 USD. In the next quarter EPS is expected to reach −0.08 USD. Track more of Taysha Gene Therapies, Inc. financials and stay on top of what is up with the company.
In the next quarter Taysha Gene Therapies, Inc. revenue is expected to reach ‪2.14 M‬ USD. Check out Taysha Gene Therapies, Inc. revenue and earnings and make informed decisions.
According to analysts, TSHA price target is 6.59 USD with a max estimate of 8.00 USD and a min estimate of 5.00 USD. Check if this forecast comes true in a year, meanwhile watch Taysha Gene Therapies, Inc. stock price chart and keep track of the current situation with TSHA news and stock market news.
We've gathered opinions of 11 analysts rating TSHA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.